Patent intelligence · US
US 8293267
Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom
Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton …
Patent details — US 8293267
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 23, 2012
- Expiration
- Oct 18, 2032
- Applicant
- Biotech, Inc.
- Claims
- 16
- CPC classes
- A61K, A61K33/38, A61K9/00, A61P
Quick answer
US 8293267 (Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom) is held by Biotech, Inc.. Status: granted. Granted Oct 23, 2012. Expires Oct 18, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Biotech, Inc.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K33/38, A61K9/00, A61P, A61P31/04
More from Biotech, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11542526
Oncolytic adenoviral vector and methods of use
granted -
US 11246930
Reoviruses having modified sequences
granted -
US 10596260
Reoviruses having modified sequences
granted -
US 10167452
Viral purification methods
granted -
US 10039827
Reoviruses having modified sequences
granted -
US 9610352
Lyophilized viral formulations
granted -
US 9610309
Liquid viral formulations
granted -
US 9365823
Virus clearance of neoplastic cells from mixed cellular compositions
granted
Frequently asked questions
What is US patent 8293267?
US 8293267 (Method for preparing an antimicrobial cotton of cellulose matrix having chemically and/or physically bonded silver and antimicrobial cotton prepared therefrom) is held by Biotech, Inc.. Status: granted. Granted Oct 23, 2012. Expires Oct 18, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8293267?
Biotech, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 66 pharmaceutical patents for this assignee.
When does US 8293267 expire?
Our index shows an expiration date of Oct 18, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.